Coronary Revascularization in Patients With Liver Cirrhosis Akira Marui, MD, PhD, Takeshi Kimura, MD, PhD, Shiro Tanaka, PhD, Senri Miwa, MD, PhD, Kazuhiro Yamazaki, MD, PhD, Kenji Minakata, MD, PhD, Tomohiro Nakata, MD, PhD, Tadashi Ikeda, MD, PhD, Yutaka Furukawa, MD, PhD, Toru Kita, MD, PhD, Ryuzo Sakata, MD, PhD The Annals of Thoracic Surgery Volume 91, Issue 5, Pages 1393-1399 (May 2011) DOI: 10.1016/j.athoracsur.2011.01.022 Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 (A) Freedom from all-cause death (all patients). (B) Freedom from all-cause death, percutaneous coronary intervention (PCI [red line]) versus coronary artery bypass graft surgery (CABG [blue line]). (C) Freedom from all-cause death, PCI (red line) versus conventional on-pump CABG (CCAB [green line]) versus off-pump CABG (OPCAB [blue line]). (D) Freedom from cardiovascular death, PCI (red line) versus CCAB (green line) versus OPCAB (blue line). The Annals of Thoracic Surgery 2011 91, 1393-1399DOI: (10.1016/j.athoracsur.2011.01.022) Copyright © 2011 The Society of Thoracic Surgeons Terms and Conditions